4//SEC Filing
Shukla Sath 4
Accession 0000950170-23-045441
CIK 0001701108other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:20 PM ET
Size
6.5 KB
Accession
0000950170-23-045441
Insider Transaction Report
Form 4
Shukla Sath
CEO & President
Transactions
- Sale
Common Stock
2023-08-28$1.26/sh−1,854$2,336→ 576,663 total - Sale
Common Stock
2023-08-29$1.30/sh−4,163$5,412→ 572,500 total
Footnotes (2)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F2]The reported transaction is a sale of common stock pursuant to a preexisting 10b5-1 plan upon the vesting of RSUs that were granted to the Reporting Person on August 26, 2021.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001782817
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 4:20 PM ET
- Size
- 6.5 KB